Johnson & Johnson Sees Heavy Put Activity as $2.68M Bet Targets Near-Term Downside
By TrendSpider Editor
A dominant bearish options contract is drawing attention in Johnson & Johnson (JNJ) today, with a single put position carrying a premium of $2,683,980 standing out against a comparatively minor call. JNJ shares are currently trading at $281.235, down 0.54% on the session, and sitting near the upper
Johnson & Johnson Sees Heavy Put Activity as $2.68M Bet Targets Near-Term Downside
A dominant bearish options contract is drawing attention in Johnson & Johnson (JNJ) today, with a single put position carrying a premium of $2,683,980 standing out against a comparatively minor call. JNJ shares are currently trading at $281.235, down 0.54% on the session, and sitting near the upper end of their 52-week range of $195.90 to $290.2495. The lopsided options flow, totaling $2,719,705 in combined premium across just two unusual contracts, suggests at least some institutional participants are positioning defensively heading into the final weeks of November 2026.
Key Drivers of the JNJ Stock Move
- Main Catalyst: Two unusual options contracts were flagged today, heavily skewed toward the put side. A put at the $280 strike expiring November 27, 2026 printed with a size of 4,836 contracts and a premium of $2,683,980, currently in the money relative to the $281.235 share price. A comparatively small call at the $282.50 strike expiring November 20, 2026 printed with a size of 152 contracts and a premium of $35,725, sitting out of the money.
- Bull Case: JNJ shares remain elevated near the top of their 52-week range, trading at $281.235 against a 52-week high of $290.2495. The call contract at the $282.50 strike, though modest in size, reflects some near-term directional interest to the upside, and the stock is well above its 52-week low of $195.90, underscoring a strong longer-term trend.
- Bear Case: The put contract at the $280 strike expiring November 27, 2026 is already in the money and carries an open interest ratio of 91%, reflecting significant existing positioning. With 4,836 contracts tied to $2,683,980 in premium, this is an outsized bet on near-term weakness, and the stock's marginal daily decline of 0.54% suggests some modest selling pressure is already present.
The forward setup for JNJ warrants close attention over the next two weeks, given that both flagged options contracts expire before the end of November 2026. The in-the-money put expiring November 27 gives bears a tight window to profit if the stock pulls back toward or below $280. With JNJ trading just $9 below its 52-week high of $290.2495, any broader market softness or company-specific news could quickly accelerate a move in either direction. Investors should monitor whether additional unusual options flow develops in the days ahead, particularly ahead of any scheduled corporate events or macroeconomic catalysts that could influence large-cap healthcare names.
JNJ Unusual Options Activity
Two unusual contracts were flagged in JNJ today, with the put side accounting for the overwhelming majority of total premium activity:
- Contract 1: Call | Strike: $282.50 | Expiry: November 20, 2026 | Volume: 152 | Open Interest: 304% of normal | Out of the money | Premium: $35,725
- Contract 2: Put | Strike: $280.00 | Expiry: November 27, 2026 | Volume: 4,836 | Open Interest: 91% | In the money | Premium: $2,683,980
The total premium across both contracts is $2,719,705, with the put representing approximately 98.7% of that figure. The in-the-money status of the put and its proximity to the current share price of $281.235 makes it a high-conviction near-term directional trade worth watching closely through the November 27 expiration.
JNJ Seasonality
Mid-to-late November has historically represented a transitional period for large-cap healthcare stocks, as institutional investors reassess portfolio positioning ahead of year-end. The concentration of these contracts in the November 20 and November 27 expiration windows suggests traders are focused on capturing any near-term volatility rather than making longer-dated macro bets.
JNJ Relative Performance
JNJ's current price of $281.235 places it roughly 43% above its 52-week low of $195.90 and within approximately 3.2% of its 52-week high of $290.2495, indicating that the stock has been among the stronger performers in the large-cap healthcare space over the trailing year. Today's modest decline of 0.54% is relatively contained, though the heavy put premium flagged in today's session suggests at least some market participants anticipate a near-term retracement from these elevated levels.
More on JNJ
- Johnson & Johnson Sees $9.18M in Unusual Options Activity Despite 2.18% Stock Decline
- Johnson & Johnson Inches Toward 52-Week High as Stock Consolidates Near $288
- Johnson & Johnson Stock Pushes to 52-Week High Territory as Shares Approach $286.07 Peak
- Johnson & Johnson Trades Just Above 52-Week High as Stock Holds Near $283.50
- Johnson & Johnson Hovers Just Below Its 52-Week High of $283.25 Despite Modest Dip
Latest Market News
- Palo Alto Networks Drops 7.94% Despite 20 Analyst Confirmations and $432 Average Price Target
- Meta Platforms Drops Nearly 6% as Shares Slide Toward 52-Week Low Territory
- Oracle Stock Craters 6.4%, Breaking Below Its 52-Week Low to $103.44
- QUALCOMM Shares Plunge 7.41% to $150.01, Nearing 52-Week Lows
- CrowdStrike Shares Crater 15% on Friday, Erasing Months of Gains in a Single Session
- Snowflake Shares Tumble 5.13% as Stock Retreats Sharply from Recent Highs